Outcome comparisons by prescribable treatment options

Kidney International, Supplement

Volumn 57, Issue 74, 2000, Pages

  Levin, Nathan W ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b RENAL RESEARCH INSTITUTE   (United States)

Author keywords

Dialysis dose; Hemodialysis; Morbidity; Mortality

Indexed keywords

ANEMIA; ARTIFICIAL KIDNEY; BLOOD PRESSURE; CALCIUM METABOLISM; COMORBIDITY; CONFERENCE PAPER; DAILY LIFE ACTIVITY; DOCTOR PATIENT RELATION; EXERCISE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY DISEASE; LIPID BLOOD LEVEL; LIPID METABOLISM; MEMBRANE PERMEABILITY; MORBIDITY; MORTALITY; NEPHROLOGIST; NUTRITION; PATIENT SATISFACTION; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VASCULAR ACCESS; WATER TREATMENT;

EID: 4243872849     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.07418.x     Document Type: Conference Paper

References (62)

1. LOWRIE EG, LAIRD NM, PARKER TF, SARGENT JA: Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Study. N Engl J Med 305:1176-1181, 1981
2. GOTCH FA, SARGENT JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28:526-534, 1985
3. KESSLER E, RITCHEY NP, CASTRO F, CACCAMO LP, CARTER KJ, ERICKSON BA: Urea reduction ratio and urea kinetic modeling: a mathematical analysis of changing dialysis parameters. Am J Nephrol 18:471-477, 1998
4. LOWRIE EG, LEW NL: The urea reduction ratio (URR): a simple method for evaluating hemodialysis treatment. Contemp Dial Nephrol 12:11-20, 1991
5. DAUGIRDAS JT: Chronic hemodialysis prescription: Urea kidney approach, in Handbook of Dialysis (2nd ed), edited by DAUGIRDAS JT, ING TS, Boston, Little, Brown, 1994, p 92-120
6. RENAL PHYSICIANS' ASSOCIATION: Clinical Practice Guideline on Adequacy of Dialysis. Washington, DC, Renal Physicians' Association, 1996
7. PORT FK, ORZOL SM, HELD PJ, WOLFE RA: Trends in treatment and survival for hemodialysis patients in the United States. Am J Kidney Dis 32(Suppl 4):S34-S38, 1998
8. NATIONAL KIDNEY FOUNDATION: NKF-DOQI Clinical practice guidelines for hemodialysis. Am J Kidney Dis 30(Suppl 2):S34-S36, 1997
9. GOTCH FA, LEVIN NW, PORT FK, WOLFE RA, UEHLINGER DE: Clinical outcome relative to the dose of dialysis is not what you think: the fallacy of the mean. Am J Kidney Dis 30:1-15, 1997
10. CHARRA B, LAURENT G, CHAZOT C, JEAN G, TERRAT JC, VANEL T: Hemodialysis trends in time, 1989 to 1998, independent of dose and outcome. Am J Kidney Dis 32(Suppl 4):S63-70, 1998
11. DAUGIRDAS JT, DEPNER TA, GOTCH FA, GREENE T, KESHAVIAH P, LEVIN NW, SCHULMAN G: Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 52:1395-1405, 1997
12. NATIONAL KIDNEY FOUNDATION: NKF-DOQI Clinical practice guidelines for hemodialysis. Am J Kidney Dis 30(Suppl 2):S38-S42, 1997
13. DEPNER T, BECK G, DAUGIRDAS J, KUSEK J, EKNOYAN G: Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose. Am J Kidney Dis 33:142-149, 1999
14. MCCLELLAN WM, SOUCIE JM, FLANDERS WD: Mortality in endstage renal disease is associated with facility-to-facility differences in adequacy of hemodialysis. J Am Soc Nephrol 9:1940-1947, 1998
15. ANDERSON JE, TORRES JR, BITTER DC, ANDERSON SC, BRIEFEL GR: Role of physician assistants in dialysis units and nephrology. Am J Kidney Dis 33:647-651, 1999
16. RONCO C, MARCELLI D: Are better outcomes in hemodialysis explained by superior ESRD care? Semin Dial 12:345-348, 1999
17. MORTELMAN AK, DUYM P, VANDENBROUCKE J, DE SMET R, DHONDT A, LESAFFER G, VERWIMP H, VANHOLDER R: Intradialytic parenteral nutrition in malnourished hemodialysis patients: a prospective long-term study. J Parenter Enteral Nutr 23:90-95, 1999
18. LEAVEY SF, STRAWDERMAN RL, JONES CA, PORT FK, HELD PJ: Simple nutritional indicators as independent predictors of mortality of hemodialysis patients. Am J Kidney Dis 31:997-1006, 1998
19. FLEISCHMANN E, TEAL N, DUDLEY J, MAY W, BOWER JD, SALAHUDEEN AK: Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55:1560-1567, 1999
20. WITKO-SARSAT V, FRIEDLANDER M, NGUYEN KHOA T, CAPEILLERE-BLANDIN C, NGUYEN AT, CANTELOUP S, DAYER JM, JUNGERS P, DRÜEKE T, DESCAMPS-LATSCHA B: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161:2524-2532, 1998
21. MIYATA T, VAN YPERSELE DE STRIHOU C, KUROKAWA K, BAYNES JW: Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 55:389-399, 1999
22. KIMMEL PL, PHILLIPS TM, SIMMENS SJ, PETERSON RA, WEIHS KL, ALLEYNE S, CRUZ I, YANOVSKI JA, VEISH JH: Immunologic function and survival in hemodialysis patients. Kidney Int 54:236-244, 1998
23. MOUSTAPHA A, GUPTA A, ROBINSON K, ARHEART K, JACOBSEN DW, SCHREIBER MJ, DENNIS VW: Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis. Kidney Int 55:1470-1475, 1999
24. DIERKES J, DOMROSE U, AMBROSCH A, BOSSELMAN HP, NEUMANN KH, LULEY C: Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease. Clin Nephrol 51:108-115, 1999
25. KIMMEL PL, PETERSON RA, WEIHS KL, SIMMENS SJ, ALLEYNE S, CRUZ I, VEIS JH: Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int 54:245-254, 1998
26. U.S. RENAL DATA SYSTEM: USRDS 1998 Annual Data Report. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 1998
27. SEHGAL AR, O'ROURKE SG, SNYDER C: Patient assessments of adequacy of dialysis and protein nutrition. Am J Kidney Dis 30:514-520, 1997
28. RUBIN HR, JENCKES M, FINK NE, MEYER K, WU AW, BASS EB, LEVIN N, POWE NR: Patient's view of dialysis care: development of a taxonomy and rating of importance of different aspects of care. CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. Am J Kidney Dis 30:793-801, 1997
29. STENVINKEL P, HEIMBURGER O, JOGESTRAND T, KARNELL A, SAMUELSSON A: Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure? Kidney Int 55:2531-2532, 1999
30. 2-microglobulin associated amyloidosis: A vanishing complication of long-term hemodialysis? Kidney Int 52:1077-1083, 1997
31. LEYPOLDT JK, CHEUNG AK, CARROLL CE, STANNARD DC, PEREIRA BJ, AGODOA LY, PORT FK: Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis 33:349-355, 1999
32. HAAG-WEBER M, HÖRL WH: Are granulocyte inhibitory proteins contributing to enhanced susceptibility to infections in uraemia? Nephrol Dial Transplant 11(Suppl 2):S98-S100, 1996
33. HÖRL WH: Neutrophil function and infections in uremia. Am J Kidney Dis 33:45-48, 1999
34. BLOEMBERGEN WE, HAKIM RM, STANNARD DC, HELD PJ, WOLFE RA, AGODOA LY, PORT FK: Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis 33:1-10, 1999
35. CHARRA B, BERGSTRÖM J, SCRIBNER BH: Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 32:720-724, 1998
36. CHARRA B, LAURENT G, CHAZOT C, JEAN G, TERRAT JC, VANEL T: Hemodialysis trends in time, 1989 to 1998, independent of dose and outcome. Am J Kidney Dis 32(Suppl 4):S63-S70, 1998
37. UEHLINGER D, KEEN M, GOTCH F: Patient survival with short time high flux dialysis therapy. J Am Soc Nephrol 4:392, 1993
38. LEVIN NW: Time on dialysis. Am J Kidney Dis 32(Suppl 4):S83-S85, 1998
39. WOODS JD, PORT FK, ORZOL S, BUONCRISTIANI U, YOUNG E, WOLFE RA, HELD PJ: Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 55:2467-2476, 1999
40. BUONCRISTIANI U: Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 13(Suppl 6):S145-S151, 1998
41. BUONCRISTIANI U, FAGUGLI R, CIAO G, CIUCCI A, CAROBI C, QUINTALIANI G, PASINI P: Left ventricular hypertrophy in daily dialysis. Miner Electrolyte Metab 25:90-94, 1999
42. PIERRATOS A: Daily hemodialysis: Why the renewed interest? Am J Kidney Dis 32(Suppl 4):S76-S72, 1998
43. GOTCH FA: The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 13(Suppl 6):10-14, 1998
44. BLOCK GA, HULBERT-SHEARON TE, LEVIN NW, PORT FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607-617, 1998
45. LEVIN NW, HULBERT-SHEARON T, STRAWDERMAN R, PORT F: Which causes of death are related to hyperphosphatemia in hemodialysis (HD) patients? J Am Soc Nephrol 9:217A, 1998
46. CHERTOW GM, DILLON M, BURKE SK, STEG M, BLEYER AJ, GARRETT BN, DOMOTO DT, WILKES BM, WOMBOLT DG, SLATOPOLSKY E: A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients. Clin Nephrol 51:18-26, 1999
47. NATIONAL KIDNEY FOUNDATION: NKF-DOQI clinical practice guidelines on anemia. Am J Kidney Dis 30(Suppl 3): S200-S201, 1997
48. BESARAB A, BOLTON WK, BROWNE JK, EGRIE JC, NISSENSON AR, OKAMOTO DM, SCHWAB SJ, GOODKIN JA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 27:584-590, 1998
49. LEVEY A: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to know? Where do we go from here? Am J Kidney Dis 32(Suppl 3):S5-S55, 1998
50. BLANKESTIJN PJ, VOS PF, RABELINK TJ, VAN RIJN HJ, JANSEN H, KOOMANS HA: High flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol 5:1703-1708, 1995
51. PAINTER P, JOHANSEN K: Physical functioning in end-stage renal disease. Adv Renal Repl Ther 6:107-194, 1999
52. SMITH JK, DYKES R, DOUGLAS JE, KRISHNASWAMY G, BERK S: Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 281:1722-1727, 1999
53. GARRED LJ, GOODWIN C, MCCREADY W, WATSON P, PAOLINI F: Determination of vascular volume refilling rates from blood volume monitoring. ASAIO Abstracts 188, 1999
54. LEYPOLDT JK, CHEUNG AK, STEUER RR, HARRIS DH, CONIS JM: Determination of circulating blood volume by continuously monitoring hematocrit during hemodialysis. J Am Soc Nephrol 6:214-219, 1995
55. LOWN B, VERRIER RL: Increased neural activity and ventricular fibrillation. N Engl J Med 294:1165-1170, 1976
56. BIGGER JT, KLEIGER RE, FLEISS JL, ROLNITZKY LM, STEINMAN RC, MILLER JP: Multicenter post infarction research group: components of heart rate variability measured during healing of acute myocardial infarction. Am J Cardiol 61:208-215, 1988
57. KAUFMAN AM, MORRIS AT, LAVARIAS VA, WANG Y, LEUNG JF, GLABMAN MB, YUSUF SA, LEVOCI AL, POLASCHEGG HD, LEVIN NW: Effects of controlled blood cooling on hemodynamic stability and urea kinetics during high-efficiency hemodialysis. J Am Soc Nephrol 9:877-883, 1998
58. CRUZ DN, MAHNENSMITH RL, BRICKEL HM, PERAZELLA MA: Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension. Am J Kidney Dis 33:920-926, 1999
59. GRABE DW, LOW CL, BAILIE GR, EISELE G: Evaluation of drug-related problems in the outpatient dialysis unit and the impact of a clinical pharmacist. Clin Nephrol 47:117-121, 1997
60. HELD PJ, WOLFE RA, GAYLIN DS, PORT FK, LEVIN NW, TURENNE MN: Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis 23:692-708, 1994
61. FELDMAN HI, BILER WB, HACKETT MH, SIMMONS CW, HOLMES JH, PAULY MV, ESCARCE JJ: Association of dialyzer reuse with hospitalization and survival rates among U.S. hemodialysis patients: do comorbidities matter? J Clin Epidemiol 52:209-217, 1999
62. CHEUNG AK, AGODOA LY, DAUGIRDAS JT, DEPNER TA, GOTCH FA, GREENE T, LEVIN NW, LEYPOLDT JK: Effects of hemodialyzer reuse on clearances of urea and beta 2-microglobulin. The Hemodialysis (HEMO) Study Group. J Am Soc Nephrol 10:117-127, 1999